West Pharmaceutical Services Inc
WST· NYSE
Released Feb 15, 2024, before the open
10-K filed Feb 20, 2024, 51 days after period end · 0000105770-24-000015
derived · Computed from the longer spans the company filed.
| Metric | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures | Q4 2020 |
|---|---|---|---|---|
| Revenue | $732.00M | $708.70M | $730.80M | $580.20M |
| Net Income | $137.00M | $103.00M |
West Pharmaceutical Services Inc · CIK 105770 · Engraved from SEC EDGAR
| $147.70M |
| $98.40M |
| EPS Diluted | — | — | — | $1.29 |
|---|
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.